Effects of Using Custom Photobiomodulation Therapy for the Treatment of Osteoarthritis of the Fingers and Rhizarthrosis
Primary Purpose
Osteoarthritis, Osteoarthritis Finger, Osteoarthritis Hand
Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Photobiomodulation therapy (PBT)
Sham Photobiomodulation therapy (Sham PBT)
Sponsored by

About this trial
This is an interventional treatment trial for Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Clinical and radiological diagnosis of OA of the fingers of the hand and Rizarthrosis
- Patients with pain for at least 3 months
- Patients undergoing treatment and rehabilitation for finger OA and rhizarthrosis
- Patient with good understanding of the Portuguese language who agrees to participate and sign the ICF
Exclusion Criteria:
- Posttraumatic arthritic changes
- Systemic inflammatory arthritis (Rheumatoid Arthritis, Lupus Erythematosus, Psoriasis…)
- Patients with local or systemic, acute or chronic infections
Sites / Locations
- Instituto Vita
Arms of the Study
Arm 1
Arm 2
Arm Type
Sham Comparator
Experimental
Arm Label
Sham (group A)
PBT (group B)
Arm Description
Treatment procedure performed with the device that will not provide the bioactive light (laser)
Treatment procedure performed with the device that will provide the bioactive light (laser)
Outcomes
Primary Outcome Measures
Change from Baseline Pain at
Visual analogue scale for pain
Change from Baseline Arm, Shoulder and Hand Disability
The Disabilities of the Arm, Shoulder and Hand Score
Secondary Outcome Measures
Change from Baseline Hand grip
Hand grip strenght measured by Digital Hand Dynamometer
Change from Baseline Pinch force
Pulp to pulp (pinch) force
Willingness to recommend the treatment
Net Promoter Score
Change from Baseline Hand Disability
Brief Michigan questionnaire
Full Information
NCT ID
NCT05041231
First Posted
August 25, 2021
Last Updated
January 20, 2023
Sponsor
Vita Care
Collaborators
Tegos S.A.
1. Study Identification
Unique Protocol Identification Number
NCT05041231
Brief Title
Effects of Using Custom Photobiomodulation Therapy for the Treatment of Osteoarthritis of the Fingers and Rhizarthrosis
Official Title
Effects of Using Custom Photobiomodulation Therapy for the Treatment of Osteoarthritis of the Fingers and Rhizarthrosis
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
August 25, 2021 (Actual)
Primary Completion Date
December 31, 2022 (Actual)
Study Completion Date
January 20, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Vita Care
Collaborators
Tegos S.A.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Osteoarthrosis (OA), a multifactorial degenerative process, is responsible for joint pain and functional limitation. In the hand, more specifically in the proximal and distal interphalangeal joints of the fingers, it is one of the sites of greatest manifestation of the disease. Numerous treatments, whether drug, rehabilitation or surgery, have been proposed with the aim of both interrupting the natural evolution of the disease and alleviating or stopping the symptoms. This study aims to evaluate the effectiveness of personalized Photobiomodulation Therapy (PBT) with regard to alleviating symptoms and improving the quality of life of these patients with the disease.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Osteoarthritis Finger, Osteoarthritis Hand, Osteoarthritis Both Hands
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
46 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sham (group A)
Arm Type
Sham Comparator
Arm Description
Treatment procedure performed with the device that will not provide the bioactive light (laser)
Arm Title
PBT (group B)
Arm Type
Experimental
Arm Description
Treatment procedure performed with the device that will provide the bioactive light (laser)
Intervention Type
Device
Intervention Name(s)
Photobiomodulation therapy (PBT)
Other Intervention Name(s)
Laser
Intervention Description
Any invasive procedures will be done. The treatment in question will be done by a device that looks like a bracelet, which is placed on the hand/fingers to emit light/laser and does not cause pain or temperature change. There will be 8 photobiomodulation sessions, 2 per week, 10 minutes each session.
The dosimetric parameters of the therapy will be carried out in a standardized and personalized way, with programming of the light and all the necessary information so that the device can carry out the application of the treatment application of electromagnetic waves in the red and infrared spectral range 660-1000 nm).
Intervention Type
Device
Intervention Name(s)
Sham Photobiomodulation therapy (Sham PBT)
Other Intervention Name(s)
Sham Laser
Intervention Description
Similar to active PBT, however, the device will not provide the active electromagnetic waves)
Primary Outcome Measure Information:
Title
Change from Baseline Pain at
Description
Visual analogue scale for pain
Time Frame
4 weeks and 2 months
Title
Change from Baseline Arm, Shoulder and Hand Disability
Description
The Disabilities of the Arm, Shoulder and Hand Score
Time Frame
4 weeks and 2 months
Secondary Outcome Measure Information:
Title
Change from Baseline Hand grip
Description
Hand grip strenght measured by Digital Hand Dynamometer
Time Frame
4 weeks and 2 months
Title
Change from Baseline Pinch force
Description
Pulp to pulp (pinch) force
Time Frame
4 weeks and 2 months
Title
Willingness to recommend the treatment
Description
Net Promoter Score
Time Frame
4 weeks and 2 months
Title
Change from Baseline Hand Disability
Description
Brief Michigan questionnaire
Time Frame
4 weeks and 2 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical and radiological diagnosis of OA of the fingers of the hand and Rizarthrosis
Patients with pain for at least 3 months
Patients undergoing treatment and rehabilitation for finger OA and rhizarthrosis
Patient with good understanding of the Portuguese language who agrees to participate and sign the ICF
Exclusion Criteria:
Posttraumatic arthritic changes
Systemic inflammatory arthritis (Rheumatoid Arthritis, Lupus Erythematosus, Psoriasis…)
Patients with local or systemic, acute or chronic infections
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mateus Saito, PhD
Organizational Affiliation
Medical Director Instituto Vita
Official's Role
Principal Investigator
Facility Information:
Facility Name
Instituto Vita
City
São Paulo
State/Province
SP
ZIP/Postal Code
05653-070
Country
Brazil
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effects of Using Custom Photobiomodulation Therapy for the Treatment of Osteoarthritis of the Fingers and Rhizarthrosis
We'll reach out to this number within 24 hrs